Trial reportFrontiers in nutrition2026
Daily intake of cuminaldehyde-rich cumin essential oil improves cognitive function in healthy elderly Japanese adults: a randomized, double-blind, placebo-controlled pilot study.
Trial report in Frontiers in nutrition, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: To extend healthspan has risen demand to maintain cognitive function through the exploitation of bioactive compounds from natural sources. We assessed the effects of daily intake of cumin essential oil (CEO), primarily composed of cuminaldehyde, on cognitive function in the elderly. Methods: Thirty-eight participants (ages 65-86) were randomly assigned to either the CEO group ( Results: The analysis revealed a significant group × time interaction for the CEO group in psychomotor speed ( Conclusion: Overall, this study suggest that the daily intake of CEO, rich in cuminaldehyde, have a beneficial effect on cognitive function in the elderly. These findings provide foundational knowledge that could contribute to strategies aimed at extending the healthy life expectancy of older adults. Clinical trial registration: https://center6.umin.ac.jp/cgi-open-bin/ctr/ctr_view.cgi?recptno=R000057216, identifier UMIN000050328.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.